-
Subject Areas on Research
-
A novel approach to the treatment of chronic allograft nephropathy.
-
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
-
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
-
A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation.
-
A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
-
A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.
-
Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and mycophenolate mofetil in a liver transplant patient: a case report and review of the literature.
-
Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism.
-
Advances in pancreas transplantation: the University of Wisconsin experience.
-
Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.
-
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
-
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.
-
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
-
Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.
-
Aplastic anaemia as an autoimmune complication of thymoma.
-
Bullous systemic lupus erythematosus in a 6-year-old boy.
-
Campath-1H in renal transplantation: The University of Wisconsin experience.
-
Can mycophenolate mofetil be tapered safely in myasthenia gravis? A retrospective, multicenter analysis.
-
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
-
Clinical trial of focal segmental glomerulosclerosis in children and young adults.
-
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.
-
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.
-
Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis.
-
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
-
Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
-
Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis.
-
Composite tissue allotransplantation: development of a preclinical model in nonhuman primates.
-
Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
-
Current therapies for lupus nephritis in an ethnically heterogeneous cohort.
-
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
-
Effect of cyclosporin pharmacokinetics on renal allograft outcome in African-Americans.
-
Effects of Immunosuppressive Medications on Mitochondrial Function.
-
Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.
-
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
-
Enteric-coated mycophenolate sodium versus mycophenolate mofetil maintenance immunosuppression: outcomes analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network database.
-
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
-
Experience with 500 simultaneous pancreas-kidney transplants.
-
First-Principles Molecular Structure Search with a Genetic Algorithm.
-
Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids.
-
Guidance for liver transplant immunosuppression.
-
Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil.
-
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
-
Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation.
-
Interleukin-15 receptor blockade in non-human primate kidney transplantation.
-
Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.
-
Lessons from two trials of mycophenolate mofetil in myasthenia gravis.
-
Living unrelated kidney donation: an underutilized resource?
-
Management of childhood onset nephrotic syndrome.
-
Management of patients with confirmed and presumed mucous membrane pemphigoid undergoing entropion repair.
-
Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.
-
Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.
-
Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients.
-
Mycophenolate mofetil in myasthenia gravis: the unanswered question.
-
Mycophenolate mofetil in the treatment of pediatric autoimmune central nervous system disease.
-
Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.
-
Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
-
Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.
-
Obesity following kidney transplantation and steroid avoidance immunosuppression.
-
Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.
-
Pharmacogenomics in pediatric rheumatology.
-
Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
-
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.
-
Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly.
-
Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.
-
Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
-
Reversal of acute allograft rejection using immunotoxin.
-
Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients.
-
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.
-
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.
-
T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil.
-
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.
-
Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone.
-
Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.
-
The influence of RS-61443 on antibody-mediated rejection.
-
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
-
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.
-
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.
-
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.
-
Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.
-
Update on new immunomodulatory agents.
-
Vasculitis and Pregnancy.
-
[IgA pemphigus. Successful treatment with mycophenolate mofetil].
-
Keywords of People